Loading...

BN N

BN

BON NATURAL LIFE LTD

(BON)

2025 6-K

Management Change

19 Mar '26

Cooperation Agreement

17 Feb '26

Sales Agreement Signed

10 Dec '25

Sales Agreement Signed

25 Nov '25

Management Change

14 Nov '25

Interim Results Decline

29 Sep '25

Sales Agreement

9 Sep '25

Compliance Regained

4 Aug '25

Sales Agreement

21 Jul '25

Compliance Update

11 Jul '25

New Partnership Agreement

2 Jul '25

Sales Agreement Signed

16 Jun '25

Share Repurchase Program

3 Jun '25

Sales Agreement Signed

22 May '25

Cooperation Agreement

16 May '25

Delisting Notice

2 May '25

Share Consolidation Details

23 Apr '25

Supply Agreement Signed

11 Apr '25

Share Consolidation Planned

2 Apr '25

Stock Offering Update

17 Mar '25

Share Changes Report

28 Feb '25

Extraordinary Meeting Notice

6 Jan '25

Corporate Reorganization

2 Jan '25

Director Resignation

18 Dec '24

Board Changes

29 Oct '24

Asset Sale Agreement

3 Oct '24

Interim Results Decline

27 Sep '24

Share Purchase Agreement

12 Sep '24

Private Offering Closed

20 May '24

Brand Partnership

14 May '24

Compliance Regained

3 May '24

Board Appointment

19 Apr '24

Reverse Split Notification

8 Apr '24

Shareholder Meeting Results

14 Mar '24

Share Consolidation Planned

23 Feb '24

External Links:

SEC

Bon Natural Life Ltd's subsidiary signed a three-year sales agreement with Tianjin Merrill-Youli Trading Co. for Ambroxide products, promising $18 million in sales. The agreement was made on May 26, 2025, and involves quality control responsibilities and payment terms.

AI Assistant

BON NATURAL LIFE LTD

2025

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.